SEC Comment Letter for PALISADE BIO, INC. (PALI) (CIK 0001357459) (PALI) — Jun 20, 2017
PALISADE BIO, INC. (PALI) (CIK 0001357459)
Date: June 20, 2017 · CIK: 0001357459 · Accession: 0000000000-17-021602
AI Filing Summary & Sentiment
Reasoning
Letter
June 20, 2017 Richard Daly President, Chief Executive Officer and Chief Financial Officer Neuralstem, Inc. 20271 Goldenrod Lane, 2nd Floor Germantown, MD 20876 Neuralstem, Inc. Registration Statement on Form S-3 Filed June 8, 2017 File No. 333-218608Re: Dear Mr. Daly: We have limited our review of your registration statement to those issues we have addressed in our comment. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this comment, we may have additional comments. Form S-3 filed June 8, 2017 Incorporation of Documents by Reference, page 15 Please incorporate by reference the Current Reports on Form 8-K filed on January 6, February 16, February 22 and March 20, 2017. See Item 12(a)(2) of Form S-3.1.
Richard Daly Neuralstem, Inc. 2 PageJune 20, 2017 We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate time for us to review any amendment prior to the requested effective date of the registration statement. Please contact Irene Paik at (202) 551-6553 with any questions. Division of Corporation Finance Office of Healthcare & Insurance cc: Raul Silvestre, Silvestre Law Group, P.C.
Show Raw Text
June 20, 2017
Richard Daly
President, Chief Executive Officer and Chief Financial Officer
Neuralstem, Inc.
20271 Goldenrod Lane, 2nd Floor
Germantown, MD 20876
Neuralstem, Inc.
Registration Statement on Form S-3
Filed June 8, 2017
File No. 333-218608Re:
Dear Mr. Daly:
We have limited our review of your registration statement to those issues we have
addressed in our comment.
Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe our comment applies to your facts and
circumstances or do not believe an amendment is appropriate, please tell us why in your
response.
After reviewing any amendment to your registration statement and the information you
provide in response to this comment, we may have additional comments.
Form S-3 filed June 8, 2017
Incorporation of Documents by Reference, page 15
Please incorporate by reference the Current Reports on Form 8-K filed on January 6,
February 16, February 22 and March 20, 2017. See Item 12(a)(2) of Form S-3.1.
Richard Daly
Neuralstem, Inc.
2 PageJune 20, 2017
We remind you that the company and its management are responsible for the accuracy
and adequacy of their disclosures, notwithstanding any review, comments, action or absence of
action by the staff.
Refer to Rules 460 and 461 regarding requests for acceleration. Please allow adequate
time for us to review any amendment prior to the requested effective date of the registration
statement.
Please contact Irene Paik at (202) 551-6553 with any questions.
Division of Corporation Finance
Office of Healthcare & Insurance
cc: Raul Silvestre, Silvestre Law Group, P.C.